
18 people risk their lives in radical experiment to reverse aging and cure disease
A biotechnology company has launched a first-of-its-kind human trial for a drug designed to turn back aspects of aging at the cellular level. The experimental therapy, known as ER-100, comes from Boston-based Life Biosciences. In June 2026, the company said…















